We are live on ! Find out more
INAB icon

IN8bio
INAB

17 hedge funds and large institutions have $1.78M invested in IN8bio in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

6% more funds holding

Funds holding: 16 → 17 (+1)

0.02% more ownership

Funds ownership: 0.16% → 0.19% (+0.02%)

36% less capital invested

Capital invested by funds: $2.77M → $1.78M (-$989K)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SPC
Sigma Planning Corp
Michigan
+$195K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$77K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$24.8K
4
BlackRock
BlackRock
New York
+$2.01K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$112

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$3.29K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.56K
3
UBS Group
UBS Group
Switzerland
-$614
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
1
Voss Capital
Texas
$439K – – –
SIG
2
Stonegate Investment Group
Alabama
$302K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$273K +$77K +1,380 +25%
SPC
4
Sigma Planning Corp
Michigan
$265K +$195K +3,492 +106%
RCG
5
Rock Creek Group
District of Columbia
$106K – – –
BCM
6
Bridgeway Capital Management
Texas
$96.2K – – –
Ensign Peak Advisors
7
Ensign Peak Advisors
Utah
$91K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$75.2K -$1.56K -28 -1%
BlackRock
9
BlackRock
New York
$42.4K +$2.01K +36 +3%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$31.8K +$24.8K +444 +119%
Northern Trust
11
Northern Trust
Illinois
$17.2K – – –
Wells Fargo
12
Wells Fargo
California
$13.2K +$56 +1 +0.3%
HighTower Advisors
13
HighTower Advisors
Illinois
$13K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$6K -$3.29K -59 -27%
UBS Group
15
UBS Group
Switzerland
$4.07K -$614 -11 -10%
Bank of America
16
Bank of America
North Carolina
$50 – – –
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– +$112 +2 New

INAB Hedge Fund Activity: Q1 2023 in Review

17 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q1 2023, worth a combined $1.78M — down 36% from $2.77M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new INAB positions and 0 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Sigma Planning Corp, adding an estimated $195K. The largest seller was Tower Research Capital (TRC), cutting an estimated $3.29K.

  • 17 institutional investors held IN8bio (INAB) as of Q1 2023, up from 16 in Q4 2022.
  • Funds reported $1.78M of IN8bio stock for Q1 2023, down 36% quarter-over-quarter.
  • 1 fund opened new IN8bio positions in Q1 2023 and 0 closed out, a net change of +1 holder.
  • The largest IN8bio buyer in Q1 2023 was Sigma Planning Corp, an estimated $195K added.
  • The largest IN8bio seller in Q1 2023 was Tower Research Capital (TRC), an estimated $3.29K sold.

Based on aggregated 13F filings for Q1 2023.